Massive data dive: how europe treats blood clots in cancer patients
NCT ID NCT04618913
Summary
This study looks back at existing medical records to understand how blood clots are treated in people with cancer across Europe. Researchers are analyzing data from thousands of patients to see which blood-thinning medications work best, what side effects occur, and how much treatment costs. The goal is to gather real-world evidence to help improve future care for cancer patients who develop blood clots.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Pfizer Investigational Site
London, United Kingdom
Conditions
Explore the condition pages connected to this study.